Trial intelligence / Profile preview

Fluticasone Propionate Nasal Spray BE Study in Seasonal Allergic Rhinitis

CTR20210440Phase 3Completed

Sponsor
Baian Pharmaceutical
Start
Mar 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate in seasonal allergic rhinitis (SAR), perennial rhinitis, sponsored by Baian Pharmaceutical. Started Mar 2021; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

seasonal allergic rhinitis (SAR)perennial rhinitis

Beyond the preview

Go deeper on CTR20210440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20210440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call